BioCloner Health is an innovative biotechnology company whose mission is to improve the quality of life and health of both humans and animals by introducing cutting-edge technologies into the medical field. Since 2016, the company has been developing its original BioCloner technology, created from scratch in Poland, which includes the BioCloner Desktop Pro 3D bioprinter along with dedicated software. This advanced machine is designed for experts in medicine and science, with applications primarily in regenerative medicine and tissue engineering. It enables the printing of three-dimensional structures using biomaterials and bioinks under sterile conditions.

The BioCloner Health team is working on creating structures that replicate human organs, synthetic menisci, and new, personalized drug therapies. BioCloner technology allows for studying disease mechanisms and transmission, as well as monitoring cellular behavior within printed structures. All of this is possible thanks to the use of biomaterials and bioinks that support the development of cultivated cells. With this approach, BioCloner Health aims to reduce animal testing, minimizing harm to their lives and health.

BioCloner Health is also actively focused on R&D, implementing its 3D bioprinters in universities and research institutions to support scientists in their daily work and help them carry out projects. The company has already introduced its machines at the Warsaw University of Technology, the Medical University of Warsaw, the AGH University of Krakow, Cracow University of Technology, and the Institute of Fundamental Technological Research, Polish Academy of Sciences. The company is also in the process of securing ISO 13485 certification, which will enable it to introduce its 3D bioprinter to the medical market.